Abstract: OBJECTIVES: Intermittent periods of hypoxemia such as during periodic breathing are associated with hypertension and increased sympathetic activity. In patients with sleep apnea syndrome, hypertension is common. Treating apnea improves hypertension and reduces sympathetic outflow. The aim of the present study was to investigate the phenomenon and mechanisms of spontaneous periodic breathing in patients with hypertension. METHOD: We examined 43 hypertensive patients with untreated hypertension without left-ventricular dysfunction, heart failure or sleep apnea syndrome. Muscle sympathetic nerve activity (MSA), heart rate (HR), blood pressure (BP) and respiration were continuously recorded at rest and during cold-pressor testing. Oxygen and a CO2-enriched gas were used to test central and peripheral chemoreceptors, respectively. Baroreceptor gain was measured using the alpha method. RESULTS: Seven out of 43 patients showed spontaneous periodic breathing while awake. No difference in MSA, HR and BP was seen between patients with and without periodic breathing at rest except the breathing pattern. However, the cold-pressor test caused a larger increase of MSA in patients with periodic breathing (203 +/-62 vs. 62 +/-8%, P < 0.0001 by ANOVA), as well as systolic (46 +/-6 vs. 25 +/-3 mmHg, P = 0.002) and diastolic BP (26 +/-5 vs. 12 +/-1 mmHg, P = 0.004, ANOVA). Baroreceptor gain was markedly higher in patients with periodic breathing. Chemoreceptor sensitivity was comparable. CONCLUSION: Spontaneous periodic breathing is relatively common in patients with hypertension and is associated with greatly enhanced responses to cold-pressor testing. We suggest increased baroreceptor gain and sympathetic outflow as a cause for the oscillatory respiration pattern via barorespiratory coupling.
Abstract
Objectives Intermittent periods of hypoxemia such as during periodic breathing are associated with hypertension and increased sympathetic activity. In patients with sleep apnea syndrome, hypertension is common. Treating apnea improves hypertension and reduces sympathetic outflow. The aim of the present study was to investigate the phenomenon and mechanisms of spontaneous periodic breathing in patients with hypertension.
Method
We examined 43 hypertensive patients with untreated hypertension without left ventricular dysfunction, heart failure or sleep apnea syndrome. Muscle sympathetic nerve activity (MSA), heart rate (HR), blood pressure (BP) and respiration were continuously recorded at rest and during cold pressor testing. Oxygen and a CO 2 -enriched gas were used to test central and peripheral chemoreceptors, respectively.
Baroreceptor gain was measured using the alpha method.
Results 7 out of 43 patients showed spontaneous periodic breathing while awake. No difference in MSA, HR and BP was seen between patients with and without periodic breathing at rest except the breathing pattern. However, the cold pressor test caused a larger increase of MSA in patients with periodic breathing (203±62 vs. 62±8%, p<0.0001 by ANOVA), as well as systolic (46±6 vs. 25±3 mmHg, p=0.002) and diastolic BP (26±5 vs. 12±1 mmHg, p=0.004, ANOVA). Baroreceptor gain was markedly higher in patients with periodic breathing. Chemoreceptor sensitivity was comparable.
Conclusion Spontaneous periodic breathing is relatively common in patients with
hypertension and is associated with greatly enhanced responses to cold pressor testing.
We suggest increased baroreceptor gain and sympathetic outflow as a cause for the oscillatory respiration pattern via baro-respiratory coupling.
Condensed Abstract
Periodic breathing, which is associated with various cardiovascular diseases was found in a considerable number of hypertensive patients. Sympathetic and blood pressure reactivity in response to the cold pressor test was greatly enhanced and baroreceptor sensitivity was markedly higher in patients with periodic breathing while chemoreceptor sensitivity was comparable between the groups. Increased baroreceptor gain and sympathetic outflow is suggested to cause the oscillatory respiration pattern via barorespiratory coupling.
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INTRODUCTION
The sympathetic nervous system (SNS) plays an important role in cardiovascular regulation. Its activity has important pathogenetic and prognostic impact in a wide spectrum of cardiovascular disorders. Thus, factors influencing the activity of the sympathetic nervous system are of major interest.
Periodic breathing (PB) of central origin such as it occurs in heart failure has been described 150 years ago by Cheyne and Stokes and is an independent marker of an increased mortality. [1] It goes along with sympathetic activation; however the pattern of activation differs from obstructive apnea. [2] The resulting blood pressure elevation is blocked by the ganglionic blocker trimethaphan and thus neuronally mediated. Lowpressure receptors do not substantially contribute to sympathetic activation since endexpiratory breath holds and the sustained Mueller maneuver increase sympathetic activity to a similar extent despite different intra-thoracic pressure. [3] Recent animal experiments indicate that chronic intermittent hypoxia leads to hypertension. In a rat model, repetitive periods of hypoxia over 30 days caused hypertension persisting beyond the exposure to intermittent hypoxia. [4] In dogs, hypoxic episodes due to repetitive airway obstruction during sleep resulted in acute transient increases in nighttime blood pressure and eventually provoked a sustained daytime hypertension. [5] It is likely that the same mechanisms are valid in humans too, since obstructive sleep apnea leads to increased SNS activity and increased daytime blood pressure. [6] [7] [8] Obstructive breathing disorders are associated with cardiovascular diseases such as hypertension, [9] [10] [11] myocardial infarction, [12] stroke, [13] and heart failure. [14] When treated with continuous positive airway pressure (CPAP) during sleep, daytime blood pressure and sympathetic activity decrease. [15, 16] Similarly, in medically treated patients with heart failure, treatment of coexisting obstructive sleep apnea by CPAP reduces systolic blood pressure, sympathetic activity, improves left ventricular function [17] and increases oxygen body stores [18] , while mild hyperoxia did not reduce sympathetic drive indicating that peripheral chemoreceptors do not contribute to sympathetic activation. [19] Slowing respiratory rate with respiratory training in patients with heart failure decreased dyspnea and increased exercise performance. [20] Thus, there is evidence that intermittent periods of hypoxia -central or obstructive -lead to elevated blood pressure both in the short and long term.
In the run-in placebo phase of a clinical trial we noticed an unexpected high prevalence of a periodic breathing pattern in awake hypertensive patients without heart failure or sleep disorder. The aim of the present study was to investigate the phenomenon and mechanisms of spontaneous PB in conscious patients with hypertension and to delineate its impact on sympathetic regulation.
METHODS

Subjects
We examined 43 patients (31 men, 12 women) with arterial hypertension (diastolic blood pressure 95 to 114 mmHg) at the end of a 3 weeks placebo washout phase of a randomized double blind trial. [21] Patients treated with vasoactive drugs, with heart failure, pulmonary or hepatic disease were excluded from the study. The study was approved by the local ethics committee and all subjects gave written informed consent prior to study begin.
Measurements and Interventions
Patients were studied fasting between 9 and 11 AM in a quiet, temperature-controlled room in the supine position at rest and during cold pressor test (CPT) as previously described. [22, 23] 
Sympathetic nerve activity
Sympathetic nerve activity was recorded continuously using microneurography as previously described. In brief, electrical activity of muscle vasoconstrictor fibers was measured in the peroneal nerve, posterior to the fibular head by use of tungsten microelectrodes (shaft diameter 200 µm, tapering to an uninsulated tip of 1-5 µm). [24, 25] A subcutaneous reference electrode was inserted 1 to 2 cm away from the recording electrode. The neural signal was amplified, filtered, rectified and integrated to obtain a mean voltage neurogram of sympathetic activity.
Measurements were taken at rest and during CPT. For the CPT, patients were asked to immerge one hand into ice water (0 °C) up to the wrist for 2 minutes. We choose to use CPT as this test is a well-known stimulus for the sympathetic nervous system. [26] Moreover, during CPT there is a positive correlation between the increases in MSA and the increases in arterial pressure and this test may unmask an increased sympathetic nervous activity, which is one of the underlying mechanisms of hypertension. [26] Peripheral chemoreceptor testing.
Patients with PB were given oxygen by mask (Intersurgical, England) to test peripheral chemoreceptors. After habituation to the mask, patients breathed room-air during 5 minutes to obtain a baseline value. Then oxygen was administered at 6 l/min for 5 minutes to deactivate peripheral chemoreceptors and test their contribution to the sympathetic drive. Oxygen was followed by room air for 5 minutes. Five hypertensive patients without PB underwent the same procedure as control.
Central chemoreceptor testing.
Patients with PB and 6 hypertensive control subjects with normal breathing pattern were tested using 7% CO 2 and 93% oxygen during 3 minutes over a mouthpiece to centrally stimulate respiration. Before the measurement, the subjects breathed room air over the mouthpiece to get used to the procedure.
Baroreceptor function. Baroreceptor function was estimated using the alpha method. [27] [28] The alpha coefficient was calculated as the squared root of the ratio of R-R interval and SBP powers [28] in the frequency domain. This relies on the assumption that the ratio between R-R interval and SBP powers in the frequency regions where they are coherent is a reflection of baroreflex function. Paced breathing use increases reliability of heart rate variability analysis. [29] Therefore, in our study all patients with PB and 6 hypertensive control subjects were studied during spontaneous breathing and paced breathing (breathing at 15/min during 3 minutes).
Echocardiography.
To exclude systolic left ventricular-dysfunction, which is associated with PB, transthoracic echocardiography was performed in patients with PB. Systolic leftventricular function was derived from biplane apical views. Left-ventricular dimensions and mass were measured using parasternal M-mode imaging. [30] Diastolic leftventricular function was assessed using mitral valve inflow and pulmonary vein flow pattern.
Exclusion of sleep apnea.
The presence of sleep apnea was excluded by history using a standard screening questionnaire [31] . 
RESULTS
Clinical characteristics
Baseline characteristics such as heart rate, systolic and diastolic blood pressure and body mass index were comparable in patients with and without PB ( Table 1 ).
In 7 out of 43 hypertensive patients (16%) PB at rest was confirmed by a distinct very low frequency peak in the breathing spectrum, corresponding to a cycle length of approximately 35 seconds. In hypertensive patients with spontaneous PB, these verylow-frequency oscillations did translate into corresponding very-low-frequency oscillations of heart rate and blood pressure (Figure 1) . Echocardiography was performed in 6 of the 7 patients with PB. All of them had normal systolic function without regional wall motion abnormalities. Mean left ventricular muscle mass index was 121±9 g/m 2 . Diastolic dysfunction (mitral inflow, pulmonary vein flow) was present in 5 out of 6 patients.
Cold pressor test
Among the hypertensive study population, resting MSA did not differ between patients with PB and without PB (45.7±5 vs. 49.2±1.6 bursts/min, 73±6 vs. 75±2 bursts/100 heart beats respectively, ns.). During CPT patients with PB showed a larger increase of MSA (+203±62 vs. +62±8%, p<0.0001, Figure 2 A), systolic (+46±6 vs. +25±3 mmHg, p=0.002) and diastolic blood pressure (+26±5 vs. +12±1 mmHg, p=0.004) compared to patients without PB (Figure 2 B) . Heart rate similarly increased in patients with PB (+ 5.5±1.9 min -1 , p=0.02 vs.
baseline) and patients without PB (+6.6±0.9, p<0.0001 vs. baseline). baseline) ( Table 2) . Oxygen-breathing for 5 minutes slightly decreased diastolic blood pressure in patients without PB but had no effect on MSA.
Peripheral chemoreceptor deactivation with O 2 breathing
Central respiratory stimulation by CO 2 breathing
Central respiratory stimulation by breathing of CO 2 -enriched gas equally increased minute ventilation in patients with PB (96 ± 37 %, p < 0.05 vs. baseline) and in patients without PB (96 ± 32 %, p < 0.05 vs. baseline) as well as MSA (4.2±1.3 b/min, p=0.03
and 87±40% of total activity, p=0.007) and (2.4±0.7 b/min, p=0.02 and 55±50% of total activity, p=0.03) respectively ( Table 2) . Systolic blood pressure increased in patients with PB by 4.4±1.5 mmHg, p=0.03 and in patients without PB (6.5±1.7 mmHg, p=0.009) without any difference between groups. Diastolic blood pressure remained unchanged in patients with PB (1.3±0.6 mmHg, ns.) and increased (3.1±1.2 mmHg, p=0.04) in patients without PB. Heart rate increased by 1.9±0.7 bpm in the group with periodic breathing (p=0.05 vs. baseline) and 1.4±0.7 bpm in the group without PB (p= ns.).
Paced breathing
Paced breathing ( 
Baroreceptor function
Baroreceptor sensitivity in the high frequency range was comparable in patients with PB (10.2±2.5 ms/mmHg) and patients without PB (10.5±1.2 ms/mmHg), whereas in the low frequency range the sensitivity was significantly higher in patients with PB (10.4±1.0 ms/mmHg) compared to patients without periodic breathing (5.2±0.5 ms/mmHg, p<0.0001, Figure 3 ).
DISCUSSION
This study shows that spontaneous PB is relatively common in awake hypertensive patients without sleep apnea, left ventricular dysfunction or heart failure. Spontaneous PB was associated with a markedly enhanced reactivity of blood pressure and sympathetic activity to a physiologic stimulus. The sympathetic response to the cold pressor test was markedly more pronounced compared to controls. An increased sympathetic nervous activity has a negative prognostic impact in patients with cardiovascular disease such as heart failure, [33] myocardial infarction, [34] and stroke. [35] Baroreceptor gain for slow changes of blood pressure was considerably higher in patients with PB representing increased controller gain in the baroreceptor feedback loop. by a reflex mechanism, while hypotension has stimulatory effects upon breathing. [36] Indeed, marked blood pressure surges were followed by cyclic depression of respiration or apnea in our patients. A study in patients with pacemakers and sleep apnea syndrome showed that the stabilization of heart rate and in turn blunting baroreceptormediated oscillations of cardiac output by atrial overdrive pacing reduces the severity of the breathing disorder. [37] Conversely, central and peripheral chemoreceptors do not seem to be involved in the underlying sympathetic dysregulation, as CO 2 -breathing and hyperoxic deactivation of peripheral chemoreceptors led to similar respiration responses in our patients with and without PB. Baroreceptor gain in the low frequency range however, was twice as pronounced in patients with PB compared to the control group, indicating that arterial baroreceptors are much more sensitive to slow changes of blood pressure in patients with PB.
Chemoreflex physiology is complex and the exact mechanisms by which both peripheral and central chemoreceptors are activated remains unclear. Periodic breathing of central origin is thought to origin from instability of the feedback circuit. Although such loops act to minimize effects of disturbances on the output, they can become oscillatory. In heart failure patients, periodic breathing is common and an increased sensitivity to CO 2 has been found. [38] We hypothesized initially that an increased controller gain of chemoreceptors would be involved in respiratory oscillations, however, in patients with or without PB, CO 2 sensitivity was comparable. Moreover, hyperoxic deactivation of peripheral chemoreceptors did not influence MSA in either of the groups but slightly lowered heart rate in both groups. The former finding is in line with the effect of oxygen breathing in heart failure patients.
[39] Thus, altered controller gain of central as well as peripheral chemoreceptors is not involved in PB in hypertensive patients.
There is widespread evidence that hypoxia acutely increases sympathetic activity and consecutively peripheral resistance and blood pressure. The hypertensive effect of chronic intermittent hypoxia outlasts hypoxemia in animal models. [4, 5] Morgan et al.
demonstrated in healthy volunteers that hypoxic hypercapnia leads to a protracted increase in MSA, whereas hyperoxic hypercapnia only transiently increases sympathetic activity indicating that hypoxemia is responsible for the effect. [40] Chronic intermittent hypoxia has thus clinically relevant prolonged effects on blood pressure in animal models.
We used a strain gauge for the assessment of breathing. The strain gauge has several disadvantages compared to the pneumotachograph. Particularly, it does not allow exact quantification of respiratory volumes. However, the use of a mouthpiece as it is required with the pneumotachograph as well as the awareness of recording substantially influences the breathing pattern. [41] We aimed to identify irregularities in the breathing pattern with minimal awareness of the subjects of the recording rather than to exactly quantify respiratory flow. For this purpose, the strain gauge method used in this study might be more appropriate.
Some limitations of our study have to be emphasized: as first the assessment of the baroreceptor function was based only on the low frequency/high frequency analysis, however, the use of paced breathing improved the reliability of spectral parameters such as LF/HF.
Moreover, even if CPT is a wide used test to increase sympathetic nervous activity this test presents indeed a large intraindividual variability (reliability) and a limited reproducibility. [42, 43] In summary our study provides evidence for the presence of PB in a considerable number of hypertensive patients. PB was associated with greatly enhanced responses to cold pressor testing, indicating a potentiation of sympathetic outflow. We suggest increased baroreceptor gain and sympathetic outflow as a cause for the oscillatory respiration pattern via baro-respiratory reflex mechanism. Increased gain of central and peripheral chemoreflexes does not seem to be an important cause. Further studies will define the incidence of PB as potential cause of arterial hypertension. In addition, interventional studies should be planned to clarify the potential therapeutic implications. Original recording of respiration, heart rate, blood pressure, and muscle sympathetic nerve activity in a hypertensive patient with normal breathing or periodic breathing and spectral analysis of the same parameters. Note the oscillatory pattern of respiration, heart rate, blood pressure and muscle sympathetic nerve activity in periodic breathing.
Abbreviations: HR: heart rate (1/min), BP: blood pressure (mmHg), MSA: muscle sympathetic nerve activity (V). Baroreceptor sensitivity in patients with (white bars) and without (black bars) periodic breathing in the high frequency (HF) and in the low frequency range (LF) calculated with the alpha method. Low frequency gain is markedly higher in patients with periodic breathing (p < 0.0001).
